menu
    • menu

    Company profile for MOMA Therapeutics

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MOMA Therapeutics is committed to discovering the next generation of precision medicines by targeting highly dynamic proteins that underlie human disease. Bringing together seminal scientific advancements in biochemistry, biophysics, structural biology, chemistry, computation, and functional genomics, the company has established the KnowledgeBase platform to exploit a key vulnerability inherent to all dynamic proteins: their d...
    MOMA Therapeutics is committed to discovering the next generation of precision medicines by targeting highly dynamic proteins that underlie human disease. Bringing together seminal scientific advancements in biochemistry, biophysics, structural biology, chemistry, computation, and functional genomics, the company has established the KnowledgeBase platform to exploit a key vulnerability inherent to all dynamic proteins: their dependence on well-coordinated, stepwise changes in protein conformation. By focusing this platform on disease-causing targets, MOMA aims to develop high-impact, precision medicines for patients with unmet medical needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MOMA TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cambridge, MA 02140
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://momatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/momatx/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/moma_tx?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MOMA Therapeutics Doses First Patient in Ph 1 Trial of MOMA-341
    MOMA Therapeutics Doses First Patient in Ph 1 Trial of MOMA-341

    17 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250717737583/en/MOMA-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-for-MOMA-341-a-Highly-Potent-and-Selective-Werner-Helicase-Inhibitor

    BUSINESSWIRE
    17 Jul 2025
    Share Share
    MOMA Therapeutics to Present Posters at AACR Annual Meeting 2025
    MOMA Therapeutics to Present Posters at AACR Annual Meeting 2025

    17 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250417674720/en/MOMA-Therapeutics-to-Present-Multiple-Posters-at-the-American-Association-for-Cancer-Research-Annual-Meeting-2025

    BUSINESSWIRE
    17 Apr 2025
    Share Share
    MOMA Therapeutics Appoints Susan Pandya, M.D., to Board of Direct
    MOMA Therapeutics Appoints Susan Pandya, M.D., to Board of Direct

    01 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250401613704/en/MOMA-Therapeutics-Appoints-Susan-Pandya-M.D.-to-Board-of-Directors-and-Expands-Management-Team

    BUSINESSWIRE
    01 Apr 2025
    Share Share
    Moma Therapeutics Licenses PARP1 Inhibitor Selectively
    Moma Therapeutics Licenses PARP1 Inhibitor Selectively

    08 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250108201446/en

    BUSINESSWIRE
    08 Jan 2025
    Share Share
    MOMA Therapeutics to Participate in Upcoming Investor Conferences
    MOMA Therapeutics to Participate in Upcoming Investor Conferences

    06 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241106454402/en

    BUSINESSWIRE
    06 Nov 2024
    Share Share
    Bayer And MOMA Therapeutics Enter Oncology Collaboration
    Bayer And MOMA Therapeutics Enter Oncology Collaboration

    08 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241008787525/en

    BUSINESSWIRE
    08 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search